Quick Answer
Evofem Biosciences, Inc. reported Shares Outstanding of 113.36 million shares for fiscal year 2024.
Evofem Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 113.36M | +466.6% |
| 2023 | 20.01M | +1931.7% |
| 2022 | 984,786 | -90.9% |
| 2021 | 10.83M | -86.7% |
| 2020 | 81.35M | +69.0% |
| 2019 | 48.14M | +86.1% |
| 2018 | 25.87M | +1142.4% |
| 2017 | 2.08M | -9.7% |
| 2016 | 2.30M | -83.2% |
| 2015 | 13.75M | +0.6% |
| 2014 | 13.67M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 123.96M | +23.6% | +4.5% |
| June 30, 2025 | 118.66M | +43.3% | +4.7% |
| March 31, 2025 | 113.36M | +132.7% | +0.0% |
| December 31, 2024 | 113.36M | +466.6% | +13.0% |
| September 30, 2024 | 100.33M | +1666.3% | +21.1% |
| June 30, 2024 | 82.83M | +3181.3% | +70.0% |
| March 31, 2024 | 48.71M | +2719.4% | +143.5% |
| December 31, 2023 | 20.01M | +1931.7% | +252.2% |
- Evofem Biosciences, Inc. showed an increase of +466.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2024 period, Evofem Biosciences, Inc.’s shares outstanding has grown by 729.2% (from 13.67 million shares to 113.36 million shares).
- The most recent figure is from Evofem Biosciences, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: